Alerts will be sent to your verified email
Verify Email
HALDER
|
Halder Venture
|
Astal Laboratories
|
Balgopal Commercial
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.11 % | 5.72 % | 19.17 % |
|
5yr average Equity Multiplier
|
5.19 | 1.45 | 1.21 |
|
5yr Average Asset Turnover Ratio
|
1.86 | 0.4 | 0.22 |
|
5yr Avg Net Profit Margin
|
1.35 % | 3.54 % | 401.47 % |
|
Price to Book
|
2.19 | 7.26 | 5.62 |
|
P/E
|
78.55 | 32.39 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
115.43 Days | 83.93 Days | 4318.31 Days |
|
Inventory Days
|
76.19 Days | 12.25 Days | 1685.56 Days |
|
Days Receivable
|
65.32 Days | 123.54 Days | 0.0 |
|
Days Payable
|
23.45 Days | 125.63 Days | 58.43 Days |
|
5yr Average Interest Coverage Ratio
|
3.07 | 21.93 | 1370.87 |
|
5yr Avg ROCE
|
25.82 % | 7.95 % | 20.78 % |
|
5yr Avg Operating Profit Margin
|
4.63 % | 4.11 % | -59.92 % |
|
5 yr average Debt to Equity
|
2.76 | 0.08 | 0.01 |
|
5yr CAGR Net Profit
|
29.92 % | 289.2 % | n/a |
|
5yr Average Return on Assets
|
2.34 % | 3.24 % | 15.89 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.84 % | 18.19 % | 45.43 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.75 % |
|
Change in Promoter Holding (3 Yrs)
|
8.16 % | -49.99 % | 39.12 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Halder Venture
|
Astal Laboratories
|
Balgopal Commercial
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|